Stock Research: DaVita

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

DaVita

NYQ:DVA US23918K1088
71
  • Value
    79
  • Growth
    71
  • Safety
    Safety
    67
  • Combined
    96
  • Sentiment
    10
  • 360° View
    360° View
    71
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

DaVita Inc. is a healthcare provider focused on kidney care services. It primarily operates in kidney care, providing dialysis and administrative services, and integrated kidney care services for patients with chronic kidney failure and end-stage kidney disease. The company operates in the United States and internationally. In the last fiscal year, the company had a market cap of $10610 million, profits of $4217 million, revenue of $12816 million, and 76000 employees.

more

ANALYSIS: With an Obermatt 360° View of 71 (better than 71% compared with alternatives), overall professional sentiment and financial characteristics for the stock DaVita are above average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for DaVita. The consolidated Value Rank has an attractive rank of 79, which means that the share price of DaVita is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 79% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 71, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 67. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 10. Professional investors are more confident in 90% other stocks. ...read more

more
Index
D.J. US Health Care
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 11-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
79 65 42 76
Growth
71 53 43 45
Safety
Safety
67 23 27 52
Sentiment
10 41 71 33
360° View
360° View
71 39 44 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
20 13 7 5
Opinions Change
35 22 72 50
Pro Holdings
n/a 85 100 79
Market Pulse
31 52 38 36
Sentiment
10 41 71 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
79 65 42 76
Growth
71 53 43 45
Safety Safety
67 23 27 52
Combined
96 46 16 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
65 53 54 66
Price vs. Earnings (P/E)
72 66 88 71
Price vs. Book (P/B)
3 1 6 11
Dividend Yield
93 75 1 84
Value
79 65 42 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
32 26 19 24
Profit Growth
78 43 70 52
Capital Growth
46 46 34 60
Stock Returns
77 75 87 53
Growth
71 53 43 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
15 13 14 16
Refinancing
89 40 42 59
Liquidity
61 47 54 63
Safety Safety
67 23 27 52

Similar Stocks

Discover high‑ranked alternatives to DaVita and broaden your portfolio horizons.

Toll Brothers

NYQ:TOL
Country: USA
Industry: Homebuilding
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Bunge

NYQ:BG
Country: USA
Industry: Agricultural Products
Size: X-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: